United States · Clinical Trials startup
United States · RENOVION
RENOVION is a clinical stage pharmaceutical company that provides nebulized therapy.
Funding reportedLast round: Undisclosed round
What company datasets say RENOVION raised
Funding, as reported
Reported in all$29Min dollars
Rounds7
Last roundUndisclosed round
Last round dateMar 2023
Investors listed2
SEC Form D$32M sold, 8 filings, last Mar 2023
Founders and team
From RENOVION's own website and the SEC filings it signed: 5 on the team.
- Dan CopelandChief Executive Officer
- Marilyn ThompsonHead of Finance
- Will AndersonClinical Program Manager
- Daniel W. CopelandExecutive Officer, Directori
- Richard W. MattinglyDirector
On the board, as filediDerek W. WinstanlyJon W. CivitareseThomas U. Barton
Clinical Trials in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put RENOVION in front of investors. Or tell us what we have wrong.